Taxus paclitaxel cardiovascular data

Three-year, follow-up data from the double-blind, U.S. TAXUS IV trial in 1,314 evaluable patients showed that there were no new cases of stent thrombosis from year 2 to year 3. The 3-year TLR rate was...